Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Clinical Pharmacokinetics
|
April 22, 2024
Development of a Weight-Band Dosing Approach for Vosoritide in Children with Achondroplasia Using a Population Pharmacokinetic Model
Yulan Qi, Ming Liang Chan, Diane R Mould, et al.
Plos One
|
September 9, 2017
Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
Richard Baguma, Adam Penn-Nicholson, Erica Smit, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 21, 2024
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life
Ravi Savarirayan, Melita Irving, William R Wilcox, et al.
Nature Neuroscience
|
July 21, 2015
The role of ventral striatal cAMP signaling in stress-induced behaviors
Florian Plattner, Kanehiro Hayashi, Adan Hernández, et al.
Clinical Pharmacokinetics
|
August 25, 2021
Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia
Ming Liang Chan, Yulan Qi, Kevin Larimore, et al.
Frontiers in Immunology
|
March 15, 2021
Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
Richard Baguma, Stanley Kimbung Mbandi, Miguel J Rodo, et al.
Vaccine
|
July 6, 2025
Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C
Timothy F Spracklen, Jonathan Day, Hamza Van Der Ross, et al.
The New England Journal of Medicine
|
July 4, 2019
C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
Ravi Savarirayan, Melita Irving, Carlos A Bacino, et al.
Hemasphere
|
June 8, 2026
Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis-endemic setting
Katherine Antel, Nina Xiong, Mwanasha Merrill, et al.
The Lancet. Child & Adolescent Health
|
November 20, 2023
Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
Ravi Savarirayan, William R Wilcox, Paul Harmatz, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Clinical Pharmacokinetics
|
April 22, 2024
Development of a Weight-Band Dosing Approach for Vosoritide in Children with Achondroplasia Using a Population Pharmacokinetic Model
Yulan Qi, Ming Liang Chan, Diane R Mould, et al.
Plos One
|
September 9, 2017
Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
Richard Baguma, Adam Penn-Nicholson, Erica Smit, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 21, 2024
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life
Ravi Savarirayan, Melita Irving, William R Wilcox, et al.
Nature Neuroscience
|
July 21, 2015
The role of ventral striatal cAMP signaling in stress-induced behaviors
Florian Plattner, Kanehiro Hayashi, Adan Hernández, et al.
Clinical Pharmacokinetics
|
August 25, 2021
Pharmacokinetics and Exposure-Response of Vosoritide in Children with Achondroplasia
Ming Liang Chan, Yulan Qi, Kevin Larimore, et al.
Frontiers in Immunology
|
March 15, 2021
Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
Richard Baguma, Stanley Kimbung Mbandi, Miguel J Rodo, et al.
Vaccine
|
July 6, 2025
Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C
Timothy F Spracklen, Jonathan Day, Hamza Van Der Ross, et al.
The New England Journal of Medicine
|
July 4, 2019
C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
Ravi Savarirayan, Melita Irving, Carlos A Bacino, et al.
Hemasphere
|
June 8, 2026
Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis-endemic setting
Katherine Antel, Nina Xiong, Mwanasha Merrill, et al.
The Lancet. Child & Adolescent Health
|
November 20, 2023
Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
Ravi Savarirayan, William R Wilcox, Paul Harmatz, et al.
Page
of 10